Nigam Neha, Rastogi Archana, Bhatt Pavni, Bihari Chhagan
Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Department of Pathology, Institute of Liver and Biliary Sciences, New Delhi, India.
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):259-264. doi: 10.1016/j.jceh.2022.10.011. Epub 2022 Nov 7.
BACKGROUND/AIMS: The liver is often involved in both primary and secondary forms of amyloidosis. Significant clinical evidence of portal hypertension is relatively uncommon and seems to be related to the reduced sinusoidal lumen and increased resistance to blood flow due to massive perisinusoidal amyloid deposits. The relationships between the pattern and extent of amyloid deposition in patients presenting with portal hypertension have not yet been clearly demonstrated. This study is focusing on the topographic distribution of amyloidosis in patients presenting with portal hypertension.
The study included biopsy-proven cases of hepatic amyloidosis. The clinical, biochemical, and serological data, involvement of the extrahepatic organs, and HVPG values were recorded. Tissue sections were re-evaluated for the distribution patterns of amyloid deposits.
We had 41 patients with hepatic amyloidosis, of which, 32 were male. A mixed pattern (sinusoidal and vascular) was the most common (32/41; 78%). Hepatic venous pressure gradient was available in 21 cases. Portal hypertension was found in 14 patients (14/21; 67%). Cases of portal hypertension were found to have a sinusoidal pattern (3/14; 21.4%), vascular pattern (1/14; 7.1%), or a mixed sinusoidal and vascular pattern (10/14; 71.4%). Those not having portal hypertension showed hepatic artery (HA) involvement in 6/7 (85.7%) cases. A comparative analysis between portal hypertension (PTH) and non-PTH groups showed that HA amyloid deposition was dominant in the non-PTH group (6/7; 85.7%) and sinusoidal deposition in the PTH group (13/14; 92.8%). The difference was found to be significant ( < 0.05).
We found that portal hypertension was noted in cases with diffuse sinusoidal deposition or mixed sinusoidal with portal vein deposition. In the non-PHT group, the deposition was mainly in HA alone.
背景/目的:肝脏常参与原发性和继发性淀粉样变性。门静脉高压的显著临床证据相对少见,似乎与大量窦周淀粉样沉积导致的肝血窦腔减小和血流阻力增加有关。门静脉高压患者淀粉样沉积的模式和范围之间的关系尚未明确阐明。本研究聚焦于门静脉高压患者淀粉样变性的地形分布。
本研究纳入经活检证实的肝淀粉样变性病例。记录临床、生化和血清学数据、肝外器官受累情况及肝静脉压力梯度(HVPG)值。对组织切片重新评估淀粉样沉积的分布模式。
我们有41例肝淀粉样变性患者,其中32例为男性。混合模式(血窦和血管)最为常见(32/41;78%)。21例患者有肝静脉压力梯度数据。14例患者(14/21;67%)存在门静脉高压。门静脉高压病例呈现血窦模式(3/14;21.4%)、血管模式(1/14;7.1%)或血窦与血管混合模式(10/14;71.4%)。无门静脉高压的患者中,6/7(85.7%)例有肝动脉(HA)受累。门静脉高压(PTH)组和非PTH组的比较分析显示,HA淀粉样沉积在非PTH组占主导(6/7;85.7%),而血窦沉积在PTH组占主导(13/14;92.8%)。差异有统计学意义(<0.05)。
我们发现弥漫性血窦沉积或血窦与门静脉混合沉积的病例存在门静脉高压。在非门静脉高压组,沉积主要仅见于肝动脉。